Pharmaceutical industry supports COP28 health stance in joint statement

As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.
2028 marks the halfway point from the agreement made at COP21 to halve emissions by 2030 to be able to limit global warming to 1.5 degrees as opposed to pre-industrial levels by 2050.
With this in mind H.E. Dr Sultan Ahmed Al Jaber, President for COP28 UAE is hoping that they can use COP28 to take stock of the current plans in place and to refocus efforts around the climate agenda to stay on track.
A number of declarations have been made at COP28, with support from countries all over the world. Particularly encouraging to see is the COP28 UAE Declaration on Climate and Health, which has accumulated endorsements from 132 countries, one of the most championed declarations from the congress.
The declaration states that: ‘Climate change is the greatest threat to human lives, health, livelihoods, and well-being in the 21st century and amplifies peace and security issues.’ This echoes what many in the health industry have been saying for years, finally on a global stage.
As a part of highlighting particular issues at the congress in Dubai they have been holding thematic days, with sessions covering important issues within a certain trope. Pertinent to health was Day 3, the 3rd December, which was denoted the Health, Relief, Recovery & Peace Day. This was the first ever day dedicated to health in relation to climate action, demonstrating the importance the congress are putting into addressing the needs of the planet and it’s people.
On 3rd December ABPI, EFPIA, Farmindustria, IFPMA, IMC, JPMA, Leem, PhRMA, and vfa released a joint statement commending the impetus COP28 has put on health this year, especially through the first declaration on Climate and Health.
Pharmaceutical companies and bodies have been taking serious measures to act against climate change, setting ambitious Net Zero targets across the board and pushing for greater transparency and collaboration across the whole value chain. The statement from these bodies emphasises the cross industry collaboration and how important it is for this sentiment to be voiced on global platforms.
See the full statement here.
Related News
-
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News CPHI Podcast Series: Packaging expert perspectives at Pharmapack 2025
This month's podcast episode sounds a little different, covering the latest event in Paris – Pharmapack 2025. Digital Editor Lucy Chard speaks to several experts direct from the floor of the show, bringing you right in on the action.&nbs... -
News Closing 2024 with Editors' picks of top articles from the past year
Coming to the end of 2024 and it’s certainly been a busy year, for CPHI and for the rest of the pharmaceutical and healthcare industry. Topics of conversation throughout the last 12 months have been varied, touching on the technical, to the polit... -
News SCHOTT Pharma’s sustainable journey with CPHI
Sustainability is of paramount importance in the pharmaceutical industry. See how a recent partnership between CPHI and SCHOTT Pharma has helped to highlight and accelerate their sustainability journey to reach global goals. -
News CPHI Podcast Series: Investing in a vision for the future of life sciences
In this episode Lucy Chard is joined by Rajiv Khatau to discuss the importance of looking into new therapeutic areas and some of the more niche areas of pharmaceuticals, and investing in the future of the industry. -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance